Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI

Histone deacetylases regulate a wide variety of cellular functions and have been implicated in redifferentiation of various tumors. Histone deacetylase inhibitors (HDACi) are potential pharmacologic agents to improve outcomes for patients with gliomas. We assessed the therapeutic efficacy of belinos...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurbani, Saumya S., Yoon, Younghyoun, Weinberg, Brent D., Salgado, Eric, Press, Robert H., Cordova, J. Scott, Ramesh, Karthik K., Liang, Zhongxing, Velazquez Vega, Jose, Voloschin, Alfredo, Olson, Jeffrey J., Schreibmann, Eduard, Shim, Hyunsuk, Shu, Hui-Kuo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Grapho Publications, LLC 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403031/
https://www.ncbi.nlm.nih.gov/pubmed/30854442
http://dx.doi.org/10.18383/j.tom.2018.00031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403031/
https://www.ncbi.nlm.nih.gov/pubmed/30854442
http://dx.doi.org/10.18383/j.tom.2018.00031

Ejemplares similares